{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:55:10Z","timestamp":1791910510256,"version":"4.3.4"},"reference-count":79,"publisher":"MDPI AG","issue":"15","license":[{"start":{"date-parts":[[2022,7,23]],"date-time":"2022-07-23T00:00:00Z","timestamp":1658534400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Inflammasomes are intracellular multimeric complexes that cleave the precursors of the IL-1 family of cytokines and various proteins, found predominantly in cells of hematopoietic origin. They consist of pattern-recognition receptors, adaptor domains, and the enzymatic caspase-1 domain. Inflammasomes become activated upon stimulation by various exogenous and endogenous agents, subsequently promoting and enhancing inflammatory responses. To date, their function has been associated with numerous pathologies. Most recently, many studies have focused on inflammasomes\u2019 contribution to hematological diseases. Due to aberrant expression levels, NLRP3, NLRP1, and NLRC4 inflammasomes were indicated as predominantly involved. The NLRP3 inflammasome correlated with the pathogenesis of non-Hodgkin lymphomas, multiple myeloma, acute myeloid leukemia, lymphoid leukemias, myelodysplastic neoplasms, graft-versus-host-disease, and sickle cell anemia. The NLRP1 inflammasome was associated with myeloma and chronic myeloid leukemia, whereas NLRC4 was associated with hemophagocytic lymphohistiocytosis. Moreover, specific gene variants of the inflammasomes were linked to disease susceptibility. Despite the incomplete understanding of these correlations and the lack of definite conclusions regarding the therapeutic utility of inflammasome inhibitors, the available results provide a valuable basis for clinical applications and precede upcoming breakthroughs in the field of innovative treatments. This review summarizes the latest knowledge on inflammasomes in hematological diseases, indicates the potential limitations of the current research approaches, and presents future perspectives.<\/jats:p>","DOI":"10.3390\/ijms23158129","type":"journal-article","created":{"date-parts":[[2022,7,24]],"date-time":"2022-07-24T22:49:02Z","timestamp":1658702942000},"page":"8129","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Inflammasomes\u2014New Contributors to Blood Diseases"],"prefix":"10.3390","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0255-3138","authenticated-orcid":false,"given":"Jaromir","family":"Tomasik","sequence":"first","affiliation":[{"name":"Department of Hematology, Transplantation and Internal Medicine, Medical University of Warsaw, 02-097 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3858-8180","authenticated-orcid":false,"given":"Grzegorz W\u0142adys\u0142aw","family":"Basak","sequence":"additional","affiliation":[{"name":"Department of Hematology, Transplantation and Internal Medicine, Medical University of Warsaw, 02-097 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,7,23]]},"reference":[{"key":"ref_1","unstructured":"Punt, J., Stranford, S.A., Jones, P.P., and Owen, J.A. (2019). Innate Immunity. Kuby Immunology, WH Freeman."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/s41590-021-00886-5","article-title":"NLRP3 inflammasome in cancer and metabolic diseases","volume":"22","author":"Sharma","year":"2021","journal-title":"Nat. Immunol."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Fusco, R., Siracusa, R., Genovese, T., Cuzzocrea, S., and Di Paola, R. (2020). Focus on the Role of NLRP3 Inflammasome in Diseases. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21124223"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Kelley, N., Jeltema, D., Duan, Y., and He, Y. (2019). The NLRP3 Inflammasome: An Overview of Mechanisms of Activation and Regulation. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20133328"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1083\/jcb.201602089","article-title":"The cell biology of inflammasomes: Mechanisms of inflammasome activation and regulation","volume":"213","author":"Sharma","year":"2016","journal-title":"J. Cell Biol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1189\/jlb.3MR0516-224R","article-title":"Caspase-1 as a multifunctional inflammatory mediator: Noncytokine maturation roles","volume":"100","author":"Sun","year":"2016","journal-title":"J. Leukoc. Biol."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Urwanisch, L., Luciano, M., and Horejs-Hoeck, J. (2021). The NLRP3 Inflammasome and Its Role in the Pathogenicity of Leukemia. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22031271"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/s41408-021-00547-8","article-title":"Therapeutic targeting of the inflammasome in myeloid malignancies","volume":"11","author":"Chakraborty","year":"2021","journal-title":"Blood Cancer J."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"155850","DOI":"10.1016\/j.cyto.2022.155850","article-title":"Interleukin-1 (IL-1) and the inflammasome in cancer","volume":"153","author":"Pretre","year":"2022","journal-title":"Cytokine"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.immuni.2013.11.010","article-title":"The Interleukin-1 Family: Back to the Future","volume":"39","author":"Garlanda","year":"2013","journal-title":"Immunity"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/MOH.0000000000000658","article-title":"The Nlrp3 inflammasome\u2014The evolving story of its positive and negative effects on hematopoiesis","volume":"28","author":"Ratajczak","year":"2021","journal-title":"Curr. Opin. Hematol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1182\/bloodadvances.2020003475","article-title":"Oxidized mitochondrial DNA released after inflammasome activation is a disease biomarker for myelodysplastic syndromes","volume":"5","author":"Ward","year":"2021","journal-title":"Blood Adv."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"3026","DOI":"10.1038\/s41375-021-01332-z","article-title":"An evidence that SARS-CoV-2\/COVID-19 spike protein (SP) damages hematopoietic stem\/progenitor cells in the mechanism of pyroptosis in Nlrp3 inflammasome-dependent manner","volume":"35","author":"Kucia","year":"2021","journal-title":"Leukemia"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","article-title":"The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic\/Dendritic Neoplasms","volume":"36","author":"Khoury","year":"2022","journal-title":"Leukemia"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.annonc.2020.11.002","article-title":"Myelodysplastic syndromes: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"32","author":"Fenaux","year":"2021","journal-title":"Ann. Oncol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2960","DOI":"10.1182\/blood-2016-07-730556","article-title":"The NLRP3 inflammasome functions as a driver of the myelodysplastic syndrome phenotype","volume":"128","author":"Basiorka","year":"2016","journal-title":"Blood"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Graf, J.R., Forster, S., Bruehl, F.K., Banz, Y., Hallal, M., Brodard, J., Bacher, V.U., Allam, R., Sch\u00fcrch, C.M., and Bonadies, N. (2021). Diagnostic and Prognostic Implications of Caspase-1 and PD-L1 Co-Expression Patterns in Myelodysplastic Syndromes. Cancers, 13.","DOI":"10.3390\/cancers13225712"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"9626","DOI":"10.18632\/aging.102409","article-title":"Cellular senescence induced by S100A9 in mesenchymal stromal cells through NLRP3 inflammasome activation","volume":"11","author":"Shi","year":"2019","journal-title":"Aging"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1182\/blood-2018-10-844654","article-title":"The central role of inflammatory signaling in the pathogenesis of myelodysplastic syndromes","volume":"133","author":"Sallman","year":"2019","journal-title":"Blood"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.lfs.2016.09.019","article-title":"Polymorphisms of Interlukin-1\u03b2 rs16944 confer susceptibility to myelodysplastic syndromes","volume":"165","author":"Yin","year":"2016","journal-title":"Life Sci."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S0140-6736(16)32407-2","article-title":"Non-Hodgkin lymphoma","volume":"390","author":"Armitage","year":"2017","journal-title":"Lancet"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"108571","DOI":"10.18632\/oncotarget.21010","article-title":"NLRP3 inflammasome activation plays a carcinogenic role through effector cytokine IL-18 in lymphoma","volume":"8","author":"Zhao","year":"2017","journal-title":"Oncotarget"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"5687","DOI":"10.2147\/JIR.S329090","article-title":"Genetic Polymorphisms in NLRP3 Inflammasome-Associated Genes in Patients with B-Cell Non-Hodgkin\u2019s Lymphoma","volume":"14","author":"Liu","year":"2021","journal-title":"J. Inflamm. Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.canlet.2020.10.024","article-title":"NLRP3 inflammasome upregulates PD-L1 expression and contributes to immune suppression in lymphoma","volume":"497","author":"Lu","year":"2021","journal-title":"Cancer Lett."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.virol.2021.12.002","article-title":"The danger molecule HMGB1 cooperates with the NLRP3 inflammasome to sustain expression of the EBV lytic switch protein in Burkitt lymphoma cells","volume":"566","author":"Reinhart","year":"2022","journal-title":"Virology"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1421795","DOI":"10.1155\/2020\/1421795","article-title":"Adenosine-Induced NLRP11 in B Lymphoblasts Suppresses Human CD4+ T Helper Cell Responses","volume":"2020","author":"Ozel","year":"2020","journal-title":"J. Immunol. Res."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1074\/jbc.RA117.000152","article-title":"The NLR family pyrin domain\u2013containing 11 protein contributes to the regulation of inflammatory signaling","volume":"293","author":"Ellwanger","year":"2018","journal-title":"J. Biol. Chem."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"16047","DOI":"10.1038\/nrdp.2016.47","article-title":"Sj\u00f6gren syndrome","volume":"2","author":"Baldini","year":"2016","journal-title":"Nat. Rev. Dis. Prim."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jaut.2018.02.010","article-title":"Systemic activation of NLRP3 inflammasome in patients with severe primary Sj\u00f6gren\u2019s syndrome fueled by inflammagenic DNA accumulations","volume":"91","author":"Vakrakou","year":"2018","journal-title":"J. Autoimmun."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/joim.12631","article-title":"The P2X7 receptor-NLRP3 inflammasome complex predicts the development of non-Hodgkin\u2019s lymphoma in Sjogren\u2019s syndrome: A prospective, observational, single-centre study","volume":"282","author":"Baldini","year":"2017","journal-title":"J. Intern. Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"668369","DOI":"10.3389\/fimmu.2021.668369","article-title":"NLRP3 Regulates IL-4 Expression in TOX+ CD4+ T Cells of Cutaneous T Cell Lymphoma to Potentially Promote Disease Progression","volume":"12","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1111\/cas.12971","article-title":"Induction of apoptosis by HBI-8000 in adult T-cell leukemia\/lymphoma is associated with activation of Bim and NLRP3","volume":"107","author":"Hasegawa","year":"2016","journal-title":"Cancer Sci."},{"key":"ref_34","first-page":"470","article-title":"The Diagnosis and Treatment of Multiple Myeloma","volume":"113","author":"Gerecke","year":"2016","journal-title":"Dtsch. Arztebl. Int."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.ccell.2018.02.007","article-title":"Dysregulated IL-18 Is a Key Driver of Immunosuppression and a Possible Therapeutic Target in the Multiple Myeloma Microenvironment","volume":"33","author":"Nakamura","year":"2018","journal-title":"Cancer Cell"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1016\/j.immuni.2021.07.002","article-title":"\u03b22-microglobulin triggers NLRP3 inflammasome activation in tumor-associated macrophages to promote multiple myeloma progression","volume":"54","author":"Hofbauer","year":"2021","journal-title":"Immunity"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1179\/1607845415Y.0000000029","article-title":"Dysregulation of the NLRP3 inflammasome complex and related cytokines in patients with multiple myeloma","volume":"21","author":"Li","year":"2016","journal-title":"Hematology"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"7569809","DOI":"10.1155\/2018\/7569809","article-title":"The Genetic Polymorphisms of NLRP3 Inflammasome Associated with T Helper Cells in Patients with Multiple Myeloma","volume":"2018","author":"Zhao","year":"2018","journal-title":"J. Immunol. Res."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"114","DOI":"10.4065\/84.2.114","article-title":"Induction of a Chronic Disease State in Patients With Smoldering or Indolent Multiple Myeloma by Targeting Interleukin 1\u03b2-Induced Interleukin 6 Production and the Myeloma Proliferative Component","volume":"84","author":"Lust","year":"2009","journal-title":"Mayo Clin. Proc."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"661939","DOI":"10.3389\/fimmu.2021.661939","article-title":"NLRP3 Inflammasome Promotes the Progression of Acute Myeloid Leukemia via IL-1\u03b2 Pathway","volume":"12","author":"Zhong","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_41","first-page":"7031","article-title":"Aberrant NLRP3 inflammasome associated with aryl hydrocarbon receptor potentially contributes to the imbalance of T-helper cells in patients with acute myeloid leukemia","volume":"14","author":"Jia","year":"2017","journal-title":"Oncol. Lett."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.canlet.2021.06.014","article-title":"NLRP3-activated bone marrow dendritic cells play antileukemic roles via IL-1\u03b2\/Th1\/IFN-\u03b3 in acute myeloid leukemia","volume":"520","author":"Liu","year":"2021","journal-title":"Cancer Lett."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s00109-020-02011-9","article-title":"Chronic stress promotes acute myeloid leukemia progression through HMGB1\/NLRP3\/IL-1\u03b2 signaling pathway","volume":"99","author":"Liu","year":"2021","journal-title":"J. Mol. Med."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.molimm.2018.07.002","article-title":"Inhibition of ER stress-related IRE1\u03b1\/CREB\/NLRP1 pathway promotes the apoptosis of human chronic myelogenous leukemia cell","volume":"101","author":"Xu","year":"2018","journal-title":"Mol. Immunol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.humimm.2017.10.013","article-title":"The genetic polymorphism and expression profiles of NLRP3 inflammasome in patients with chronic myeloid leukemia","volume":"79","author":"Zhang","year":"2018","journal-title":"Hum. Immunol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/ng.3283","article-title":"NALP3 inflammasome upregulation and CASP1 cleavage of the glucocorticoid receptor cause glucocorticoid resistance in leukemia cells","volume":"47","author":"Paugh","year":"2015","journal-title":"Nat. Genet."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"501","DOI":"10.3389\/fendo.2019.00501","article-title":"Investigation of NF-\u03baB-94ins\/del ATTG and CARD8 (rs2043211) Gene Polymorphism in Acute Lymphoblastic Leukemia","volume":"10","author":"Zhang","year":"2019","journal-title":"Front. Endocrinol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"9869","DOI":"10.1038\/s41598-021-89310-4","article-title":"Genetic polymorphisms of inflammasome genes associated with pediatric acute lymphoblastic leukemia and clinical prognosis in the Brazilian Amazon","volume":"11","author":"Alves","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"26280","DOI":"10.1038\/srep26280","article-title":"Involvement of the P2X7-NLRP3 axis in leukemic cell proliferation and death","volume":"6","author":"Salaro","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.blre.2016.05.001","article-title":"Hemophagocytic syndromes (HPSs) including hemophagocytic lymphohistiocytosis (HLH) in adults: A systematic scoping review","volume":"30","author":"Hayden","year":"2016","journal-title":"Blood Rev."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1111\/apa.15900","article-title":"Hyperinflammation: On the pathogenesis and treatment of macrophage activation syndrome","volume":"110","author":"Andersson","year":"2021","journal-title":"Acta Paediatr."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/s41435-020-0098-4","article-title":"The genetics of macrophage activation syndrome","volume":"21","author":"Schulert","year":"2020","journal-title":"Genes Immun."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1038\/ng.3089","article-title":"An activating NLRC4 inflammasome mutation causes autoinflammation with recurrent macrophage activation syndrome","volume":"46","author":"Canna","year":"2014","journal-title":"Nat. Genet."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12969-016-0130-4","article-title":"Macrophage Activation Syndrome: Different mechanisms leading to a one clinical syndrome","volume":"15","author":"Bracaglia","year":"2017","journal-title":"Pediatr. Rheumatol. Online J."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1182\/blood-2017-12-820852","article-title":"Interleukin-18 diagnostically distinguishes and pathogenically promotes human and murine macrophage activation syndrome","volume":"131","author":"Weiss","year":"2018","journal-title":"Blood"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1016\/j.jaci.2016.10.022","article-title":"Life-threatening NLRC4-associated hyperinflammation successfully treated with IL-18 inhibition","volume":"139","author":"Canna","year":"2017","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.bbmt.2008.11.008","article-title":"Inflammation and Bone Marrow Transplantation","volume":"15","author":"Hill","year":"2009","journal-title":"Biol. Blood Marrow Transplant."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"38444","DOI":"10.18632\/oncotarget.6307","article-title":"Inflammasome effects in GvHD","volume":"6","author":"Koehn","year":"2015","journal-title":"Oncotarget"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1084\/jem.20130084","article-title":"The Nlrp3 inflammasome regulates acute graft-versus-host disease","volume":"210","author":"Jankovic","year":"2013","journal-title":"J. Exp. Med."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1182\/blood-2015-03-634691","article-title":"GVHD-associated, inflammasome-mediated loss of function in adoptively transferred myeloid-derived suppressor cells","volume":"126","author":"Koehn","year":"2015","journal-title":"Blood"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1182\/blood.2019001950","article-title":"Danger-associated extracellular ATP counters MDSC therapeutic efficacy in acute GVHD","volume":"134","author":"Koehn","year":"2019","journal-title":"Blood"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1182\/blood-2014-12-617258","article-title":"MicroRNA-155\u2013deficient dendritic cells cause less severe GVHD through reduced migration and defective inflammasome activation","volume":"126","author":"Chen","year":"2015","journal-title":"Blood"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1016\/j.bbmt.2018.07.026","article-title":"Loss of NLRP3 Function Alleviates Murine Hepatic Graft-versus-Host Disease","volume":"24","author":"Zhu","year":"2018","journal-title":"Biol. Blood Marrow Transplant."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"17828","DOI":"10.1038\/srep17828","article-title":"Busulfan and cyclosphamide induce liver inflammation through NLRP3 activation in mice after hematopoietic stem cell transplantation","volume":"5","author":"Qiao","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.cyto.2011.08.013","article-title":"Increased concentrations of IL-18 and uric acid in sickle cell anemia: Contribution of hemolysis, endothelial activation and the inflammasome","volume":"56","author":"Cerqueira","year":"2011","journal-title":"Cytokine"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1182\/bloodadvances.2018021709","article-title":"The platelet NLRP3 inflammasome is upregulated in sickle cell disease via HMGB1\/TLR4 and Bruton tyrosine kinase","volume":"2","author":"Vogel","year":"2018","journal-title":"Blood Adv."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.bbrc.2021.03.115","article-title":"NLRP3 inflammasome and bruton tyrosine kinase inhibition interferes with upregulated platelet aggregation and in vitro thrombus formation in sickle cell mice","volume":"555","author":"Vogel","year":"2021","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1007\/s00011-021-01461-2","article-title":"Effect of lysed and non-lysed sickle red cells on the activation of NLRP3 inflammasome and LTB4 production by mononuclear cells","volume":"70","author":"Pitanga","year":"2021","journal-title":"Inflamm. Res."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1164\/rccm.201807-1370OC","article-title":"Platelet Extracellular Vesicles Drive Inflammasome\u2013IL-1\u03b2\u2013Dependent Lung Injury in Sickle Cell Disease","volume":"201","author":"Vats","year":"2020","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1111\/bjh.15117","article-title":"Platelets at the crossroads of thrombosis, inflammation and haemolysis","volume":"180","author":"Vogel","year":"2018","journal-title":"Br. J. Haematol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"e001466","DOI":"10.1136\/jitc-2020-001466","article-title":"Blockade of AIM2 inflammasome or \u03b11-AR ameliorates IL-1\u03b2 release and macrophage-mediated immunosuppression induced by CAR-T treatment","volume":"9","author":"Liu","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.3389\/fimmu.2019.02538","article-title":"Pharmacological Inhibitors of the NLRP3 Inflammasome","volume":"10","author":"Zahid","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/imr.12908","article-title":"Therapeutic modulation of inflammasome pathways","volume":"297","author":"Chauhan","year":"2020","journal-title":"Immunol. Rev."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/mi.2017.19","article-title":"Inflammasomes and intestinal inflammation","volume":"10","author":"Zmora","year":"2017","journal-title":"Mucosal Immunol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"3769","DOI":"10.4049\/jimmunol.1701628","article-title":"Deletion of Inflammasome Components Is Not Sufficient To Prevent Fatal Inflammation in Models of Familial Hemophagocytic Lymphohistiocytosis","volume":"200","author":"Viel","year":"2018","journal-title":"J. Immunol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nrg2484","article-title":"RNA-Seq: A revolutionary tool for transcriptomics","volume":"10","author":"Wang","year":"2009","journal-title":"Nat. Rev. Genet."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/978-1-4939-9240-9_10","article-title":"Single-Cell RNA-Sequencing of Peripheral Blood Mononuclear Cells with ddSEQ","volume":"1979","author":"Khan","year":"2019","journal-title":"Methods Mol. Biol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"e12127","DOI":"10.1002\/jev2.12127","article-title":"Inflammasome-induced extracellular vesicles harbour distinct RNA signatures and alter bystander macrophage responses","volume":"10","author":"Budden","year":"2021","journal-title":"J. Extracell. Vesicles"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/s41409-020-01134-4","article-title":"Taming the beast: CRS and ICANS after CAR T-cell therapy for ALL","volume":"56","author":"Sheth","year":"2020","journal-title":"Bone Marrow Transplant."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/15\/8129\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:55:29Z","timestamp":1760140529000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/15\/8129"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,23]]},"references-count":79,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2022,8]]}},"alternative-id":["ijms23158129"],"URL":"https:\/\/doi.org\/10.3390\/ijms23158129","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,23]]}}}